scholarly journals Transthoracic Guidance Of Percutaneous Tricuspid Valve Repair: a case report

2021 ◽  
Author(s):  
Alexandru Patrascu ◽  
Donat Binder ◽  
Benjamin Polleit ◽  
Ilka Ott
Keyword(s):  
High Risk ◽  
Tricuspid Valve ◽  
Symptom Control ◽  
Interventional Therapy ◽  
Tricuspid Valve Repair ◽  
Medical Procedure ◽  
Valve Repair ◽  
Percutaneous Mitral Valve Repair ◽  
Complex Anatomy ◽  
Procedural Success

Abstract Background Percutaneous tricuspid valve (TV) repair for tricuspid regurgitation (TR) is arising as a viable treatment option in high-risk patients and can lead to symptom control an improvement in quality of life (QoL). Newest devices have greatly increased safety and efficacy of interventional TR therapy. However, as with any emerging medical procedure, safety aspects need to be considered and procedural risks gradually reduced. Case summary We present the case of an 87-year-old woman with massive TR despite successful percutaneous mitral valve repair. The patient was turned down for surgery and eventually underwent percutaneous TV repair using the TriClipTM (Abbott Medical) device. Significant TR reduction with sustained procedural success at thirty-day follow-up were associated with functional and clinical improvement. Transthoracic echocardiographic guidance of the procedure, thanks to excellent parasternal TV visualization, is highlighted, while the complex anatomy of the TV is pointed out. Discussion TR is an individual predictor of morbidity but frequently found in elderly patients who are deemed very high risk for surgical treatment. This case underscores the use of modern interventional techniques and devices for addressing TR and improving QoL, whether as a stand-alone procedure or as part of complete interventional therapy of the atrioventricular valves.

scholarly journals Transfemoral Tricuspid Valve Repair Using a Percutaneous Mitral Valve Repair System

2016 ◽  
Vol 67 (7) ◽  
pp. 889-890 ◽  
Author(s):  
Joachim Schofer ◽  
Claudia Tiburtius ◽  
Christoph Hammerstingl ◽  
Per-Olof Dickhaut ◽  
Julian Witt ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Repair ◽  
Tricuspid Valve ◽  
Tricuspid Valve Repair ◽  
Repair System ◽  
Valve Repair ◽  
Percutaneous Mitral Valve Repair

1385Combined tricuspid and mitral vs. isolated mitral valve repair for severe mitral and tricuspid regurgitation: An analysis from TriValve and TRAMI registries

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
M Mehr ◽  
M Taramasso ◽  
T Ourrak ◽  
P Lurz ◽  
R S Von Bardeleben ◽  
...  
Keyword(s):  
High Risk ◽  
Mitral Valve ◽  
Tricuspid Valve ◽  
Tricuspid Regurgitation ◽  
Therapeutic Option ◽  
Tricuspid Valve Repair ◽  
Concomitant Treatment ◽  
Valve Repair ◽  
Treatment Groups ◽  
Significant Clinical Improvement

Abstract Background Edge-to-edge repair has been shown to be a successful therapeutic option for patients with severe mitral regurgitation (MR). Lately, it has also been emerging as a treatment perspective for severe tricuspid regurgitation (TR) in patients at high-risk for cardiac surgery. In patients, with both severe MR and TR the best treatment strategy for patients at high risk for surgery is unknown. Purpose and methods We retrospectively analyzed data from the international multicentre TriValve (Transcatheter Tricuspid Valve Therapies) registry and from the German multicentre TRAMI (Transcatheter Mitral Valve Interventions) registry. All patients included into the analysis had both severe MR and TR. Patients from the TRAMI registry (n=106) were treated with edge-to-edge repair in mitral position only. In patients from the TriValve registry (n=122), both valves were treated concomitantly in compassionate and/or off-label use. We sought to compare baseline characteristics, procedural data and 1-year mortality in both treatment groups. Results 228 patients (77±8 years; 44.3% female) were included into the analysis. All patients showed significant dyspnea on exposure (NYHA III or IV 93.9%). Kidney function (eGFR 42 ml/min/1,72m2) and the proportion of patients with significant pulmonary hypertension (59.0%) and COPD (23.7%) did not differ between the groups, but the proportion of patients with LV-EF <30% (34.9% vs. 18.0%, p<0.001) were higher in the TRAMI cohort. At discharge, MR was comparably reduced in both groups (MR ≤ I° 75.9% vs. 77.3%, p=0.67). While all patients in both registries had significant TR at baseline, the percentage of patients with TR≥3+ at discharge was reduced to 18.6% in TriValve by the placement of 2±1 tricuspid clips/patient. The rate of in-hospital adverse events and the time of hospitalization did not differ in both cohorts. At 1-year, overall all-cause mortality was 34.0% in the TRAMI cohort and 16.4% in the TriValve cohort (p=0.0002, see figure; after adjustment for LVEF <30%: p=0.049). The rate of patients with NYHA ≤ II at 1 year did not differ between both cohorts (69.4% vs. 67.0%, p=0.54). 1-year mortality TriValve vs. TRAMI Conclusion Transcatheter mitral and tricuspid valve repair can result in a significant clinical improvement at 1 year. The concomitant treatment of both valve regurgitations may result in an improved survival, which needs to be confirmed in dedicated prospective trials.

scholarly journals Transcatheter tricuspid valve repair: early experience in the Netherlands

2021 ◽  
Author(s):  
F. Meijerink ◽  
K. T. Koch ◽  
R. J. de Winter ◽  
M. Holierook ◽  
B. J. W. M. Rensing ◽  
...  
Keyword(s):  
New York ◽  
Tricuspid Valve ◽  
Heart Association ◽  
Early Experience ◽  
Tricuspid Valve Repair ◽  
York Heart Association Class ◽  
Valve Repair ◽  
Association Class ◽  
New York Heart Association ◽  
Procedural Success

Abstract Background Symptomatic tricuspid regurgitation (TR) is increasingly prevalent and impairs quality of life and survival, despite medical treatment. Transcatheter tricuspid valve repair (TTVR) has recently become available as a treatment option for patients not eligible for tricuspid valve surgery. In this study we describe the early experience with TTVR in the Netherlands. Methods All consecutive patients scheduled for TTVR in two tertiary hospitals were included in the current study. Patients were symptomatic and had severe functional TR. TTVR was performed either with the MitraClip (off-label use) or dedicated TriClip delivery system and device. Procedural success was defined as achievement of clip implantation, TR reduction ≥ 1 grade and no need for re-do surgical or transcatheter intervention. Clinical improvement was evaluated after 4 weeks. Results Twenty-one patients (median age 78 years, 33% male, 95% New York Heart Association class ≥ 3, 100% history of atrial fibrillation) underwent TTVR. Procedural success was achieved in 16 patients, of whom 15 reported symptomatic improvement (New York Heart Association class 1 or 2). There was no in-hospital mortality and no major complications occurred. Baseline glomerular filtration rate and TR coaptation gap size were associated with procedural success. Conclusion The current study showed that TTVR seems a promising treatment option for patients with severe functional TR deemed high risk for surgery. Successful TR reduction is most likely in patients with limited coaptation gap size and strongly determines clinical benefit. Adequate patient selection and timing of treatment seem essential for an optimal patient outcome.

scholarly journals Right ventricle dysfunction assessment for transcatheter tricuspid valve repair: a matter of debate

2021 ◽  
Author(s):  
Alberto Preda ◽  
Francesco Melillo ◽  
Luca Liberale ◽  
Fabrizio Montecucco ◽  
Eustachio Agricola
Keyword(s):  
Right Ventricle ◽  
Tricuspid Valve ◽  
Tricuspid Valve Repair ◽  
Valve Repair ◽  
Right Ventricle Dysfunction

Tricuspid valve repair via partial sternotomy for traumatic valve insufficiency

2021 ◽  
pp. 021849232110100
Author(s):  
Motohiro Maeda ◽  
Jiro Honda ◽  
Yosuke Ishi
Keyword(s):  
Tricuspid Valve ◽  
Chest Trauma ◽  
Right Heart Failure ◽  
Tricuspid Valve Repair ◽  
Valve Repair ◽  
Cardiac Trauma ◽  
Partial Sternotomy ◽  
Tricuspid Valve Insufficiency ◽  
Valve Insufficiency ◽  
Early Surgical Intervention

Tricuspid valve insufficiency rarely follows a blunt chest trauma. When the tricuspid valve is solely injured, the cardiac trauma may stay asymptomatic and tolerable, which often makes it difficult to determine the indication for surgery. We report a case of a patient with tricuspid regurgitation secondary to trauma due to a motorcycle accident. The patient was initially asymptomatic, but shortness of breath emerged two years after the accident. He underwent the tricuspid valve repair with chordae reconstruction and annuloplasty via lower partial sternotomy. We advocate that early surgical intervention prevents right heart failure, atrial fibrillation, and valve replacement.

scholarly journals IMPROVEMENTS IN PATIENT-REPORTED SLEEP AFTER TRANSCATHETER TRICUSPID VALVE REPAIR

2021 ◽  
Vol 77 (18) ◽  
pp. 1203
Author(s):  
Christine Chung ◽  
Shannon M.E. Murphy ◽  
Sarah Mollenkopf ◽  
Nancy Redeker ◽  
Philip Green ◽  
...  
Keyword(s):  
Tricuspid Valve ◽  
Tricuspid Valve Repair ◽  
Valve Repair ◽  
Patient Reported
Sign in / Sign up

Export Citation Format

Share Document